Items where authors include "Chatelus, E."

Article

Di Donato, S. orcid.org/0000-0003-1256-0761, Pauling, J.D., Ramjug, S. et al. (149 more authors) (2025) Temporal trends in vascular medication use in 8079 patients with systemic sclerosis: insights to inform future trials and therapeutic strategies from the EUSTAR cohort. Rheumatology. keaf290. ISSN 1462-0324

Roth, E., Bruni, C., Petelytska, L. et al. (244 more authors) (2025) Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort. Rheumatology. keaf016. ISSN 1462-0324

Velauthapillai, A., Bootsma, M.F.R., Bruni, C. et al. (118 more authors) (2024) Preventive effects of early immunosuppressive treatment on the development of interstitial lung disease in systemic sclerosis. Rheumatology. keae375. ISSN 1462-0324

Deibel, E. orcid.org/0000-0003-4652-9826, Carreira, P.E., Vonk, M. orcid.org/0000-0002-2266-9907 et al. (61 more authors) (2024) Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time? Arthritis Care & Research, 76 (1). pp. 88-97. ISSN 2151-464X

Proceedings Paper

D'Alessandro, R., Rodolfi, S., Calot, A. et al. (20 more authors) (2025) ABS0554 FEATURES OF ANTI-FIBRILLARIN POSITIVE SYSTEMIC SCLEROSIS PATIENTS AND ETHNIC DIFFERENCES: A EUROPEAN MULTICENTRIC COHORT. In: Annals of the Rheumatic Diseases. EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain. Elsevier , pp. 2294-2295.

Guler, A.A., Hughes, M., De Luca, G. et al. (17 more authors) (2025) OP0219 CLINICAL CHARACTERISTICS AND RISK FACTORS FOR CALCINOSIS CUTIS IN SYSTEMIC SCLEROSIS: INSIGHTS FROM THE EUROPEAN SCLERODERMA TRIAL AND RESEARCH GROUP (EUSTAR) DATABASE. In: Annals of the Rheumatic Diseases. EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain. BMJ Publishing Group , pp. 183-184.